Post on 14-Dec-2015
SCBMDN - AGM
Achievements and Future Plans
Dr Heather HolmesManager SCBMDN
At our last AGM
4 steering committee meetings
Representatives from 14 HBs
PTH
No constitution No manager No website Pathology Harmony Workforce data No Diagnostic
Steering Group
In 2011-2012
Manager appointed Constitution and Terms of Reference Website Pathology Harmony Workforce data HbA1c, PSA, CA125 Annual Report and Work Plan
Constitution
What? Why? Who? How? When?
Website
Pathology Harmony
Test Interval Test Interval
Sodium 133-146 mmol/L Calcium 2.2-2.6 mmol/L
Potassium 3.5-5.3 mmol/L Phosphate 0.8-1.5 mmol/L
Chloride 95-108 mmol/L Magnesium 0.7-1.0 mmol/L
Bicarbonate 22-29 mmol/L Protein 60-80 g/L
Urea 2.5-7.8 mmol/L Albumin 35-50 g/L
Creatinine (M) 50-120 umol/L Bilirubin <21 umol/L
Creatinine (F) 50-100 umol/L ALP 30-130 U/L
Urate (M) 200-430 umol/L ALT 5-55 U/L
Urate (F) 140-360 umol/L AST 10-45 U/L
Osmolality 275-295 mmol/kg CK (M) 40-320 U/L
CK (F) 36-200 U/L
Workforce data
0
1
2
3
4
5
6
7
8
30-35 35-40 40-45 45-50 50-55 55-60 60-65
Medical
Clinical Scientist
BMS
HbA1c
Single unit (mmol/mol) reporting
Use in diagnosis
Tumour markers
Diagnostic Steering Group
DSGSMGC
SG
Effective
Delivery Group
Quality Alliance Board
HSCMB
18 weeks RTT
Programme Board
SPAN MDICN SCB MDNBacteriology/Virology
MDN
Scottish Cancer
Taskforce
PET
Advisory
Group
Cervical Cytology
Laboratory
Consortia
Steering Group
Breast and Cervical
Screening National
UK National Screening
Committee
Bowel Screening
Programme Board
AAA Screening
Programme Board
Scottish Medical and
Scientific Advisory
Committee
NPF
NSD
Efficiency Portfolio Board
Annual Report - Administration
Feb 2012 Mar 2012
Steering Committee
Manager
Constitution
Communication
Feb 2012 Mar 2012
Health Board Representation
Other Stakeholders
Wider network – Invitation to AGM
Website
Diagnostic Steering Group
Clinical Effectiveness
Feb 2012 Mar 2012
PTH
Adjusted calcium
Pathology Harmony
HbA1c
Data
Feb 2012 Mar 2012
Workforce
Plans for 2012-2013
Communication
– Video-conferencing
– Patient/user representation
– Website
– Meeting summaries
Clinical effectiveness
– Pathology Harmony
– Clinical Outcome measures
– Tumour markers
Data
– Workforce
– Workload
– Keele
– Quality / key performance indicators
Next steps
• Approval of work plan
• Funding?
• Sharing resources with other MDNs?
• Demonstrating impact
– Outcome measures
– Keele